Inthera Bioscience's Series A Round

Inthera Bioscience raised a round of funding on May 31, 2017.

Inthera Bioscience, founded in 2013, employs a proprietary technology platform to rationally design protein-protein interaction inhibitors. The company has discovered disruptors of hypoxia-inducible s…

Articles about Inthera Bioscience's Series A Round: